FAQ

PDGFRB NP_002600.1:p.T681I

Known as: Beta Platelet-Derived Growth Factor Receptor Thr681Ile, Platelet-Derived Growth Factor Receptor 1 Thr681Ile, Platelet-Derived Growth Factor Receptor Beta Thr681Ile 
A change in the amino acid residue at position 681 in the platelet-derived growth factor receptor beta protein where threonine has been replaced by… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2016
01220052016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Pdgfrb‐Cre targets lymphatic endothelial cells of both venous and non‐venous origins
The Pdgfrb-Cre line has been used as a tool to specifically target pericytes and vascular smooth muscle cells. Recent studies… (More)
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
Researcher of the Month
Die Anaplastische Lymphoma Kinase (ALK) ist eine Tyrosin-Rezeptor-Kinase, die durch ihre konstitutive Aktivierung nach Fusion mit… (More)
Is this relevant?
Review
2013
Review
2013
Platelet-derived growth factors and their receptors: structural and functional perspectives.
The four types of platelet-derived growth factors (PDGFs) and the two types of PDGF receptors (PDGFRs, which belong to class III… (More)
Is this relevant?
2010
2010
A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.
Increasing evidence indicates the significance of platelet-derived growth factor receptor-β (β-PDGFR) signaling in prostate… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2005
2005
The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFR and FIP1L1-PDGFR in vitro and in vivo
AMN107 is a small molecule tyrosine kinase inhibitor developed, in the first instance, as a potent inhibitor of breakpoint… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?